CHRNB4

Cholinergic Receptor Nicotinic Beta 4 Subunit

Gene Information Card

Symbol CHRNB4
Full Name cholinergic receptor nicotinic beta 4 subunit
Gene Type protein-coding
Chromosomal Location 15q14
NCBI Gene ID 1143 ncbi.nlm.nih.gov/gene/1143
Ensembl ID ENSG00000167996
UniProt ID P30926
OMIM ID 118504
HGNC ID 1964
Aliases nAChR beta4, beta4, CHRNB

Description

The CHRNB4 gene encodes the beta 4 subunit of neuronal nicotinic acetylcholine receptors (nAChRs). These receptors are pentameric ligand-gated ion channels that mediate fast synaptic transmission in the central and peripheral nervous systems. The beta 4 subunit combines with alpha subunits (e.g., alpha3, alpha5) to form functional receptors with distinct pharmacological properties. CHRNB4 is implicated in nicotine dependence, autonomic nervous system function, and various neurological disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Nicotine dependence Altered receptor function due to CHRNB4 variants may affect nicotine binding and reward pathways Multiple genome-wide association studies (GWAS) and candidate gene studies (NCBI, ClinVar)
Autonomic neuropathy Mutations in CHRNB4 can impair ganglionic nAChR function, leading to autonomic dysfunction Rare case reports and functional studies (OMIM, PubMed)
Epilepsy CHRNB4 variants may contribute to neuronal hyperexcitability via altered cholinergic signaling Limited evidence from exome sequencing studies (ClinVar)

Expression Profile

Tissue Expression
Tissue nTPM level
Adrenal gland 12.5 Medium
Brain - cortex 8.3 Low
Spinal cord 6.7 Low
Lung 2.1 Not detected
Heart 1.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.2 High expression; used in nAChR studies
HEK293T 0.8 Low endogenous expression; often used for heterologous expression
IMR-32 (neuroblastoma) 18.9 High expression; model for cholinergic neurons
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) missense <0.01% Loss of start codon; likely loss of function
c.749C>T (p.Thr250Met) missense 0.02% Alters receptor desensitization kinetics
c.1234G>A (p.Gly412Ser) missense 0.01% Reduced surface expression; dominant negative effect
Mutation functional classification

Loss of Function (LOF)

Mutations that prevent subunit assembly or reduce channel conductance (e.g., p.Met1?, p.Gly412Ser).

Gain of Function (GOF)

Not well documented for CHRNB4; some variants may increase sensitivity to acetylcholine.

Dominant Negative (DN)

p.Gly412Ser and similar mutations that impair co-assembly with wild-type subunits.

Gene Ontology (GO)

• acetylcholine-gated monoatomic cation-selective channel activity (GO:0022848) plasma membrane (GO:0005886)
synapse (GO:0045202) response to nicotine (GO:0035094)
ion transport (GO:0006811)

Pathways

Nicotinic acetylcholine receptor signaling pathway (Reactome: R-HSA-629587)
Neurotransmitter receptor binding and downstream transmission (KEGG: hsa04725)

Protein Summary

The CHRNB4 protein (UniProt P30926) is a 498-amino acid transmembrane subunit of neuronal nicotinic acetylcholine receptors. It contains an extracellular N-terminal domain with a conserved Cys-loop, four transmembrane domains (M1-M4), and a large intracellular loop between M3 and M4. The beta 4 subunit does not contribute to the acetylcholine binding site but influences channel gating, ion selectivity, and pharmacology. It is highly expressed in autonomic ganglia and certain brain regions.

Related Products

Product name Cat.No. Species Gene ID
CHRNB4 Knockout HEK293 Cell Line EDJ-KQ3485 Human 1143 Details Get a Quote
CHRNB4 Knockout A-549 Cell Line EDJ-KQ25267 Human 1143 Details Get a Quote
CHRNB4 Knockout HCT 116 Cell Line EDJ-KQ25268 Human 1143 Details Get a Quote
CHRNB4 Knockout HeLa Cell Line EDJ-KQ52907 Human 1143 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: